Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Mar 1, 2016
Insider Transaction Report
Form 4
LEBKOWSKI JANE
Pres., Research & Development
Transactions
- Award
Stock Options (right to buy)
2016-02-28+165,000→ 165,000 totalExercise: $3.64From: 2016-02-28Exp: 2026-02-28→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The stock options vest in quarterly installments over four years, with the first vesting to occur on March 31, 2016.